Use of the MyProstateScore (MPS) Test to Rule Out Clinically-Significant Cancer: Validation of a Straightforward Clinical Testing Approach

PURPOSE: The MyProstateScore (MPS) test was validated for improved detection of clinically-significant (Grade Group[GG]≥2) prostate cancer relative to PSA-based risk calculators. We sought to validate an optimal MPS threshold for clinical use in ruling-out GG≥2 cancer in men referred for biopsy. MAT...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Urol
Prif Awduron: Tosoian, Jeffrey J., Trock, Bruce J., Morgan, Todd M., Salami, Simpa S., Tomlins, Scott A., Spratt, Daniel E., Siddiqui, Javed, Kunju, Lakshmi P., Botbyl, Rachel, Chopra, Zoey, Pandian, Balaji, Eyrich, Nicholas W., Longton, Gary, Zheng, Yingye, Palapattu, Ganesh S., Wei, John T., Niknafs, Yashar S., Chinnaiyan, Arul M.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2020
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC8189629/
https://ncbi.nlm.nih.gov/pubmed/33080150
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JU.0000000000001430
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg